- Contract Awards
The Food and Drug Administration has awarded Booz Allen Hamilton (NYSE: BAH) and Octo Consulting Group spots on a potential seven-year, $300 million blanket purchase agreement to update data collection and analysis systems in support of FDAs patient safety and drug development efforts, the Washington Business Journal reported Tuesday. Oct...


